Cogstate Limited (CGS)

Welcome to InvestSMART

You are currently viewing our site as a guest, which gives you limited access to our site features. By signing up for a free membership, you will receive our Investment Opportunity newsletters and have access to additional features for finding and comparing managed funds and shares. Registration is fast and simple, so please:

Sign Up Today Ľ it's FREE! Already a member? Login now!

General Information
Company Name: Cogstate Limited
Stock Code: CGS
GICS Sub-Industry: Health Care Services
Market Cap ($M): 30
Equiv. Shares (M): 99

Current Price Data+
Current Price Open High Low Last Close Volume Price Movement
 $ 0.300 $ 0.300 $ 0.300 $ 0.300 $ 0.310 400 $ -0.010  -3.226 %

Company Overview

Business Description:
Cogstate Ltd (CGS) is a multi-faceted cognitive assessment and training company focused on the development and commercialisation of rapid, computerised tests of cognition (brain function). The Company has four distinct business units, being Clinical Trials, Axon Sports, Healthcare and Cogstate Research with 5 primary offices in Australia, America and Spain.

Financial Summary
Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2014  A -3.9 -4.3 -- 0.0 0.0 0.0 --
2013  A -2.0 -2.6 -178.8 0.0 0.0 0.0 --
2012  A 2.5 3.3 -- 6.8 0.0 0.0 --
Source: Aspect actuals / Thomson IBES estimates

Peer Comparison
EPS Growth (%) P/E (%) Dividend Yield (%)
Company Mkt Cap 2012 A 2013 F 2014 F 2012 A 2013 F 2014 F 2012 A 2013 F 2014 F
Cogstate (CGS) $31 M -- -- -- -- -- -- 0.00 -- --
Virtus Health (VRT) $643 M 1.2932 0.2014 0.1798 20.9459 17.4346 14.7781 3.23 3.55 4.20

Market Comparison
Earnings P/E Ratio P/B Ratio P/E Growth P/S Ratio
CGS -- -- 2.28 -- 2.19
Market 1.20 13.5 1.00 1.03 3.51
Sector 0.68 20.8 2.28 1.65 2.48

Name Position Start Date
Mr Martyn Kenneth Myer Chairman 01 October 1999
Mr Bradley O'Connor Chief Executive Officer 01 December 2005
Mr David Darby Executive Director 22 November 2013
Mr David Alexander Simpson Non-Executive Director 24 August 2004
Mr Richard van den Broek Non-Executive Director 26 August 2010

Name Position
Paul Maruff Chief Scientific Officer
Claire Newstead-Sinclair Company Secretary
Roger O'Sullivan General Counsel
Sophie Egholm President Clinical Trials

Substantial Shareholders
Holding Name
7,472,928 (9.64%) Asia Union Investments Pty Ltd
15,714,044 (20.28%) National Nominees Limited
12,961,831 (16.73%) Quixote Investment, LLC

Calendar of Events
Date Event
18 September 2015 Report (Annual)
19 August 2015 Report (Annual)
19 August 2015 Report (Prelim)
18 February 2015 Report (Interim)
17 February 2015 Report (Interim)
© 2011 Morningstar, Inc. All rights reserved. The data and content contained herein are not guaranteed to be accurate, complete or timely. Neither Morningstar, nor its affiliates nor their content providers will have any liability for use or distribution of any of this information. To the extent that any of the content above constitutes advice, it is general advice that has been prepared by Morningstar Australasia Pty Ltd ABN: 95 090 665 544, AFSL: 240892 (a subsidiary of Morningstar, Inc.), without reference to your objectives, financial situation or needs. Before acting on any advice, you should consider the appropriateness of the advice and we recommend you obtain financial, legal and taxation advice before making any financial investment decision. If applicable investors should obtain the relevant product disclosure statement and consider it before making any decision to invest. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). DISCLOSURE: Employees may have an interest in the securities discussed in this report. Please refer to our Financial Services Guide (FSG) for more information at


Trade Shares Online from $19.95^
Free Guides

The SMH Guide to Optimising Your Portfolio

An educational booklet that will point out what you need to know to use options effectively for additional income and risk management.

More details...


Billionaires bankroll Ten's new direction Media Network sees digital future

The Age 19/12/2013 | Ten Network's programming ambitions will be funded by a $200 million loan guaranteed by three of its billionaire owners, as the free-to-air broadcaster declared digital was the future and pointed to early signs that its switch to an older market demographic was working.

Elders alleges $24m fraud in live cattle division

The Age 19/12/2013 | Troubled rural services group Elders is threatening to call in the police over an alleged $24 million fraud by a "handful of individuals" in its live cattle exports division.

Bega Cheese holds back in three-way bidding war for WCB

The Age 19/12/2013 | Bega Cheese began the battle for Warrnambool Cheese & Butter but three months on it appears to be the first casualty of the bidding war.

Aussie hampers transition

The Age 19/12/2013 | A persistently high Australian dollar is thwarting the Reserve Bank's efforts to ease the transition of the economy away from mining.

RBA keeps its focus on lower dollar

The Age 19/12/2013 | The Reserve Bank is keeping the door open to further interest rate cuts, but believes the "significant amount" of monetary policy easing over the past two years is already stimulating growth.

Pact's struggles weigh down Orora

The Age 19/12/2013 | The underwhelming sharemarket debut of packaging company Pact Group Holdings has weighed on the demerger of Amcor and its $2 billion Australasian packaging and distribution business Orora.


Sponsored Links